Alpelisib plus fulvestrant significantly improved PFS in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer, achieving a median PFS of 7.4 months versus 2.8 months with placebo. The ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ezmekly (mirdametinib) for the treatment of ...
America is facing a food system shortage. Livestock veterinarians are the new endangered species. Farmers are losing access to the experts they need to keep our food supply safe.
Moat Index gained 1.53% in November, supported by health care and broader market participation. Merck and Amgen were top Moat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback